A novel role for AMP-kinase in the regulation of the Na+/I--symporter and iodide uptake in the rat thyroid gland

American Journal of Physiology - Cell Physiology

Volumn 300, Issue 6, 2011, Pages

  Andrade, Bruno M ^a,b   Araujo, Renata L ^a,b   Perry, Robert L S ^b   Souza, Elaine C L ^a   Cazarin, Juliana M ^a   Carvalho, Denise P ^a   Ceddia, Rolando B ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b York University   (Canada)

Author keywords

Adenosine 3',5' cyclic monophosphate; Compound C; Protein kinase A; Thyroid stimulating hormone

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENYLATE KINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXIMIDE; DACTINOMYCIN; ENZYME INHIBITOR; FORSKOLIN; IODIDE ION; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SODIUM IODIDE SYMPORTER; SODIUM ION; THYROTROPIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; THYROID CELL; THYROID GLAND;

ADENYLATE KINASE; AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; ENZYME INHIBITORS; FORSKOLIN; HYPOGLYCEMIC AGENTS; IODIDES; ISOQUINOLINES; MALE; RATS; RATS, WISTAR; RIBONUCLEOTIDES; SULFONAMIDES; SYMPORTERS; THYROID GLAND; THYROTROPIN;

RATTUS;

EID: 79957663249     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00136.2010     Document Type: Article

References (35)

1. Baratta MG, Porreca I, Di Lauro R. Oncogenic ras blocks the cAMP pathway and dedifferentiates thyroid cells via an impairment of pax8 transcriptional activity. Mol Endocrinol 23: 838-848, 2009.
2. Bizhanova A, Chop P. The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinology 150: 1084-1090, 2009.
3. Blancquaert S, Wang L, Paternot S, Coulonval K, Dumont JE, Harris TE, Roger PP. Camp-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Mol Endocrinol 24: 1453-1468, 2010.
4. 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 79: 152-159, 1994.
5. Cuthbertson DJ, Babraj JA, Mustard KJ, Towler MC, Green KA, Wackerhage H, Leese GP, Baar K, Thomason-Hughes M, Sutherland C, Hardie DG, Rennie M. 5-Aminoimidazole-4-carboxamide 1-beta-Dribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men. Diabetes 56: 2078-2084, 2007.
6. Dai G, Levy N, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 379: 458-460, 1996.
7. De la Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80: 1083-1105, 2000.
8. Ferreira AC, Lima LP, Araújo RL, Müller G, Rocha RP, Rosenthal D, Carvalho DP. Rapid regulation of thyroid sodium-iodide symporter activity by thyrotrophin and iodine. J Endocrinol 184: 69-76, 2005.
9. Freake HC, Oppenheimer JH. Thermogenesis and thyroid function. Annu Rev Nutr 15: 263-291, 1995.
10. Gaidhu MP, Ceddia RB. Remodeling glucose and lipid metabolism through AMPK activation: relevance for treating obesity and Type 2 diabetes. Clin Lipidol 4: 465-477, 2009.
11. Gaidhu MP, Fediuc S, Ceddia RB. 5-Aminoimidazole-4-carboxamide- 1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J Biol Chem 281: 25956-25964, 2006.
12. García B, Santisteban P. PI3K is involved in the IGF-I inhibition of TSH-induced sodium/iodide symporter gene expression. Mol Endocrinol 16: 342-352, 2002.
13. Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond) 32, Suppl 4: S7-S12, 2008.
14. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, Goodyear LJ. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49: 527-531, 2000.
15. Hurley RL, Barré LK, Wood SD, Anderson KA, Kemp BE, Means AR, Witters LA. Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J Biol Chem 281: 36662-36672, 2006.
16. 2+-ATPase: heat production and phospholamban alterations promoted by cold exposure and thyroid hormone. Am J Physiol Heart Circ Physiol 297: H556-H563, 2009.
17. Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 18: 141-144, 2008.
18. Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138: 2227-2232, 1997.
19. Nishida M, Yamashita K, Nukatsuka M, Otsuka M, Yoshimura Y, Kawada J. Direct evidence for ATP consumption due to iodide uptake by isolated, uncultured, pig thyroid epithelial cells. Biochem Int 21: 1143-1151, 1990.
20. Park SH, Gammon SR, Knippers JD, Paulsen SR, Rubink DS, Winder WW. Effects of thyroid state on AMP-activated protein kinase and acetyl-CoA carboxylase expression in muscle. J Appl Physiol 92: 2475-2482, 2002.
21. --symporter mutant that causes congenital I[1] transport defect. Endocrinology 49: 3077-3084, 2008.
22. Riddle C, Levy O, Carrasco N. Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 276: 21458-21463, 2001.
23. Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155: 495-512, 2006.
24. Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T. Increased expression of the Na/I[1] symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab 82: 3331-3336, 1997.
25. Schröder-van der Elst JP, van der Heide D, Kastelijn J, Rousset B, Obregón MJ. The expression of the sodium/iodide symporter is upregulated in the thyroid of fetuses of iodine-deficient rats. Endocrinology 142: 3736-3741, 2001.
26. Song Y, Massart C, Chico-Galdo V, Jin L, De Maertelaer V, Decoster C, Dumont JE, Van Sande J. Species specific thyroid signal transduction: conserved physiology, divergent mechanisms. Mol Cell Endocrinol 319: 56-62, 2010.
27. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 3: 1101-1108, 2008.
28. Vadysirisack DD, Chen ES, Zhang Z, Tsai MD, Chang GD, Jhiang SM. Identification of in vivo phosphorylation sites and their functional significance in the sodium iodide symporter. J Biol Chem 282: 36820- 36828, 2007.
29. Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13: 596-611, 1992.
30. Venkateswaran A, Marsee DK, Green SH, Jhiang SM. Forskolin, 8-Br-3',5'-cyclic adenosine 5'-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/ iodide symporter protein levels in RET/PTC1-expressing cells. J Clin Endocrinol Metab 89: 6168-6172, 2004.
31. Verhoeven AJ, Kamer P, Groen AK, Tager JM. Effects of thyroid hormone on mitochondrial oxidative phosphorylation. Biochem J 226: 183-192, 1985.
32. Wolff J. Transport of iodide and other anions in the thyroid gland. Physiol Rev 44: 45-90, 1964.
33. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142, 2001.
34. Zaballos MA, Garcia B, Santisteban P. Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Mol Endocrinol 22: 1183-1199, 2008.
35. Zor U, Kaneko T, Lowe IP, Bloom G, Field JB. Effect of thyroidstimulating hormone and prostaglandins on thyroid adenyl cyclase activation and cyclic adenosine 3,5,-monophosphate. J Biol Chem 244: 5189-5195, 1969.